<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(1)</volume><submitter>Szucs Z</submitter><funding>University of Debrecen</funding><pubmed_abstract>Gram-negative bacteria possess intrinsic resistance to glycopeptide antibiotics so these important antibacterial medications are only suitable for the treatment of Gram-positive bacterial infections. At the same time, polymyxins are peptide antibiotics, structurally related to glycopeptides, with remarkable activity against Gram-negative bacteria. With the aim of breaking the intrinsic resistance of Gram-negative bacteria against glycopeptides, a polycationic vancomycin aglycone derivative carrying an n-decanoyl side chain and five aminoethyl groups, which resembles the structure of polymyxins, was prepared. Although the compound by itself was not active against the Gram-negative bacteria tested, it synergized with teicoplanin against Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii, and it was able to potentiate vancomycin against these Gram-negative strains. Moreover, it proved to be active against vancomycin- and teicoplanin-resistant Gram-positive bacteria.</pubmed_abstract><journal>Scientific reports</journal><pagination>20921</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9719540</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Synthesis of an amphiphilic vancomycin aglycone derivative inspired by polymyxins: overcoming glycopeptide resistance in Gram-positive and Gram-negative bacteria in synergy with teicoplanin in vitro.</pubmed_title><pmcid>PMC9719540</pmcid><pubmed_authors>Ostorhazi E</pubmed_authors><pubmed_authors>Bereczki I</pubmed_authors><pubmed_authors>Szucs Z</pubmed_authors><pubmed_authors>Borbas A</pubmed_authors><pubmed_authors>Fenyvesi F</pubmed_authors><pubmed_authors>Herczegh P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis of an amphiphilic vancomycin aglycone derivative inspired by polymyxins: overcoming glycopeptide resistance in Gram-positive and Gram-negative bacteria in synergy with teicoplanin in vitro.</name><description>Gram-negative bacteria possess intrinsic resistance to glycopeptide antibiotics so these important antibacterial medications are only suitable for the treatment of Gram-positive bacterial infections. At the same time, polymyxins are peptide antibiotics, structurally related to glycopeptides, with remarkable activity against Gram-negative bacteria. With the aim of breaking the intrinsic resistance of Gram-negative bacteria against glycopeptides, a polycationic vancomycin aglycone derivative carrying an n-decanoyl side chain and five aminoethyl groups, which resembles the structure of polymyxins, was prepared. Although the compound by itself was not active against the Gram-negative bacteria tested, it synergized with teicoplanin against Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii, and it was able to potentiate vancomycin against these Gram-negative strains. Moreover, it proved to be active against vancomycin- and teicoplanin-resistant Gram-positive bacteria.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-04T07:47:55.004Z</modification><creation>2025-04-04T07:47:55.004Z</creation></dates><accession>S-EPMC9719540</accession><cross_references><pubmed>36463278</pubmed><doi>10.1038/s41598-022-24807-0</doi></cross_references></HashMap>